awmsg logo



dihydroartemisinin/piperaquine phosphate (Eurartesim®)


Reference No. 1228

Publication date:
13/08/2012


Last review date:
30/08/2016

Appraisal information

dihydroartemisinin/piperaquine phosphate (Eurartesim®) 320 mg/40 mg film-coated tablet


Company: LogixX Pharma Solutions Ltd
BNF category: Infections
NMG meeting date: 12/06/2012
AWMSG meeting date: 18/07/2012
   
   
Submission Type: Limited Submission
Status: Recommended
Advice No: 1912
Ministerial ratification: 07/08/2012

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

Dihydroartemisinin/piperaquine phosphate (Eurartesim®) is recommended as an option for use within NHS Wales for the treatment of uncomplicated Plasmodium falciparum malaria in adults, children and infants 6 months and over and weighing 5 kg or more.
Final Appraisal Recommendation (FAR)
Download
AWMSG Secretariat Appraisal Report (ASAR)
Download